Intravenous Antibiotic Treatment at Home
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: A new model of interaction across health services with use of welfare technology and telemedicine.
- Who it may be relevant to
- Registry conditions: Infection. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Norway
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Intravenous Antibiotic Treatment at Home: A New Model for Across Services Interaction With the Use of Welfare Technology and Telemedicine.
Overview
The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.
Detailed description
This research-based innovation study has an evaluation approach with follow-up evaluation as the overall approach.
The pre-project was carried out with a qualitative approach under the auspices of SINTEF 2018/2019.
The main project consists of sub-study 1 and sub-study 2 (2020/2022).
Sub-study 1: The project use an iterative, user-centered service methodology with a qualitative approach. Here, SINTEF has the main responsibility for a qualitative summary after conducting interviews, observations and group discussions with patients, next of kins and health professionals regarding the development and testing / quality assurance of the new concept / service course for home treatment.
Sub-study 2: The approach here is quantitative. Descriptive data must be obtained from the hospital and municipal patient records, patient administration system (PAS) at Kristiansund hospital, alarm data from the Regional Response Center and pump log from the individual patient's infusion pump after home treatment.
Interventions
- Other A new model of interaction across health services with use of welfare technology and telemedicine
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Primary outcome measures
- number of rehospitalisations [Time frame: 45 months]
- patient satisfaction [Time frame: 45 months]
- health personnel's opinion on patient safety [Time frame: 45 months]
Eligibility criteria
Inclusion criteria
- Main or bi-diagnosis during stay:
A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract
- Competent to give consent
- The infection can not be treated with oral antibiotics in monotherapy
- Selected IV antibiotics must be suitable for administration via selected pumps
- The patient's condition is stable and does not require frequent observation by health care professionals
- The patient is motivated and willing to participate in intravenous treatment in home hospitals
- Must, after training, demonstrate mastery of practical procedures related to pump handling and any other procedures described in the patient's treatment plan
- The home must be suitable for intravenous antibiotic treatment; access to refrigerators, hygienic conditions, social conditions
- The patient must have a mobile phone and be able to handle the system for fast and secure communication with the Regional Response Center (RRO)
Exclusion criteria
- consent not given
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Norway · 1 center
- Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling — Kristiansund
Identifiers
NCT: NCT04898452 · 2019/60